Schoenberg Mark insider trades
Schoenberg Mark has filed 33 Form 4s with the SEC that we hold, all for UroGen Pharma Ltd. (URGN), as Chief Medical Officer. Across all of them we count 1 purchase worth $2.1K and 38 sales worth $5.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($4.5M). The largest single trade was a sale of 60,677 shares of UroGen Pharma Ltd. worth $2.9M, dated 2026-08-20. Of 2 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-28 and the latest 2026-09-09.
UroGen Pharma Ltd. (URGN)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-07-26 | S, sale reported on Form 4 | 103 | $1.6K | 2021-07-28 | SEC |
| 2021-08-02 | S, sale reported on Form 4 | 243 | $3.8K | 2021-08-03 | SEC |
| 2021-10-27 | S, sale reported on Form 4 | 107 | $1.7K | 2021-10-28 | SEC |
| 2021-11-01 | S, sale reported on Form 4 | 258 | $4.4K | 2021-11-02 | SEC |
| 2021-11-18 | P, purchase reported on Form 4 | 160 | $2.1K | 2021-11-19 | SEC |
| 2022-01-26 | S, sale reported on Form 4 | 111 | $898 | 2022-01-28 | SEC |
| 2022-01-31 | S, sale reported on Form 4 | 1,099 | $8.3K | 2022-02-02 | SEC |
| 2022-01-31 | S, sale reported on Form 4 | 275 | $2.1K | 2022-02-02 | SEC |
| 2022-04-30 | S, sale reported on Form 4 | 254 | $1.7K | 2022-05-03 | SEC |
| 2022-08-01 | S, sale reported on Form 4 | 259 | $2.0K | 2022-08-25 | SEC |
| 2022-10-31 | S, sale reported on Form 4 | 258 | $3.1K | 2022-11-02 | SEC |
| 2023-01-31 | S, sale reported on Form 4 | 661 | $6.7K | 2023-02-02 | SEC |
| 2023-01-31 | S, sale reported on Form 4 | 991 | $10.0K | 2023-02-02 | SEC |
| 2023-01-31 | S, sale reported on Form 4 | 248 | $2.5K | 2023-02-02 | SEC |
| 2024-01-31 | S, sale reported on Form 4 | 758 | $11.9K | 2024-02-02 | SEC |
| 2024-01-31 | S, sale reported on Form 4 | 1,894 | $29.8K | 2024-02-02 | SEC |
| 2024-01-31 | S, sale reported on Form 4 | 1,137 | $17.9K | 2024-02-02 | SEC |
| 2024-02-01 | S, sale reported on Form 4 | 1,137 | $17.9K | 2024-02-05 | SEC |
| 2024-02-01 | S, sale reported on Form 4 | 1,894 | $29.9K | 2024-02-05 | SEC |
| 2024-02-01 | S, sale reported on Form 4 | 758 | $12.0K | 2024-02-05 | SEC |
| 2024-03-18 | S, sale reported on Form 4 | 12,000 | $168.6K | 2024-03-20 | SEC |
| 2024-06-10 | S, sale reported on Form 4 | 5,153 | $67.4K | 2024-06-11 | SEC |
| 2024-09-09 | S, sale reported on Form 4 | 859 | $11.2K | 2024-09-12 | SEC |
| 2025-01-31 | S, sale reported on Form 4 | 1,896 | $21.1K | 2025-02-04 | SEC |
| 2025-01-31 | S, sale reported on Form 4 | 759 | $8.5K | 2025-02-04 | SEC |
| 2025-06-09 | S, sale reported on Form 4 | 5,162 | $38.0K | 2025-06-11 | SEC |
| 2025-07-28 | S, sale reported on Form 4 | 5,149 | $98.6K | 2025-07-30 | SEC |
| 2025-08-11 | S, sale reported on Form 4 | 10,000 | $176.9K | 2025-08-13 | SEC |
| 2025-09-08 | S, sale reported on Form 4 | 871 | $16.6K | 2025-09-09 | SEC |
| 2025-11-19 | S, sale reported on Form 4 | 10,000 | $250.0K | 2025-11-20 | SEC |
| 2026-02-03 | S, sale reported on Form 4 | 1,843 | $36.3K | 2026-02-04 | SEC |
| 2026-02-03 | S, sale reported on Form 4 | 3,686 | $72.6K | 2026-02-04 | SEC |
| 2026-02-03 | S, sale reported on Form 4 | 1,844 | $36.3K | 2026-02-04 | SEC |
| 2026-05-08 | S, sale reported on Form 4 | 10,000 | $300.0K | 2026-05-11 | SEC |
| 2026-06-08 | S, sale reported on Form 4 | 5,222 | $142.6K | 2026-06-09 | SEC |
| 2026-06-22 | S, sale reported on Form 4 | 10,000 | $350.1K | 2026-06-24 | SEC |
| 2026-07-09 | S, sale reported on Form 4 | 10,000 | $400.0K | 2026-07-10 | SEC |
| 2026-08-20 | S, sale reported on Form 4 | 60,677 | $2.9M | 2026-08-24 | SEC |
| 2026-09-08 | S, sale reported on Form 4 | 871 | $37.4K | 2026-09-09 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1763581) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
